Kistler-Tiffany Companies’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $3.19M | Sell |
46,181
-8,035
| -15% | -$572K | 0.52% | 35 |
|
|
2023
Q1 | $4.03M | Sell |
54,216
-158
| -0.3% | -$13.2K | 0.77% | 24 |
|
|
2022
Q4 | $5.07M | Sell |
54,374
-4,323
| -7% | -$417K | 1.04% | 18 |
|
|
2022
Q3 | $5.6M | Sell |
58,697
-1,330
| -2% | -$132K | 1.27% | 17 |
|
|
2022
Q2 | $5.56M | Sell |
60,027
-2,374
| -4% | -$232K | 1.21% | 18 |
|
|
2022
Q1 | $6.32M | Sell |
62,401
-3,582
| -5% | -$376K | 1.19% | 18 |
|
|
2021
Q4 | $6.81M | Sell |
65,983
-487
| -0.7% | -$45K | 1.33% | 16 |
|
|
2021
Q3 | $5.64M | Sell |
66,470
-3,254
| -5% | -$273K | 1.28% | 18 |
|
|
2021
Q2 | $5.82M | Sell |
69,724
-83
| -0.1% | -$6.8K | 1.34% | 17 |
|
|
2021
Q1 | $5.25M | Buy |
69,807
+1,718
| +3% | +$125K | 1.36% | 15 |
|
|
2020
Q4 | $4.65M | Sell |
68,089
-281
| -0.4% | -$18.3K | 1.33% | 14 |
|
|
2020
Q3 | $3.99M | Buy |
68,370
+3,896
| +6% | +$242K | 1.28% | 15 |
|
|
2020
Q2 | $4.19M | Buy |
64,474
+12,979
| +25% | +$817K | 1.49% | 14 |
|
|
2020
Q1 | $3.83M | Hold |
51,495
| – | – | 1.35% | 14 |
|
|
2019
Q4 | $3.83M | Buy |
51,495
+2,419
| +5% | +$170K | 1.34% | 14 |
|
|
2019
Q3 | $3.1M | Buy |
49,076
+5,359
| +12% | +$318K | 1.17% | 14 |
|
|
2019
Q2 | $2.38M | Buy |
43,717
+10,285
| +31% | +$554K | 0.91% | 17 |
|
|
2019
Q1 | $1.8M | Buy |
33,432
+8,739
| +35% | +$539K | 0.75% | 23 |
|
|
2018
Q4 | $1.62M | Buy |
24,693
+1,114
| +5% | +$83.2K | 0.75% | 23 |
|
|
2018
Q3 | $1.86M | Buy |
23,579
+4,796
| +26% | +$343K | 0.77% | 20 |
|
|
2018
Q2 | $1.21M | Buy |
18,783
+1,312
| +8% | +$86.5K | 0.54% | 34 |
|
|
2018
Q1 | $1.09M | Buy |
17,471
+2,697
| +18% | +$194K | 0.45% | 43 |
|
|
2017
Q4 | $1.07M | Buy |
14,774
+2,157
| +17% | +$157K | 0.42% | 47 |
|
|
2017
Q3 | $1.03M | Buy |
12,617
+788
| +7% | +$62.3K | 0.43% | 44 |
|
|
2017
Q2 | $952K | Buy |
11,829
+2,809
| +31% | +$222K | 0.44% | 41 |
|
|
2017
Q1 | $708K | Sell |
9,020
-8
| -0.1% | -$639 | 0.33% | 51 |
|
|
2016
Q4 | $712K | Buy |
9,028
+420
| +5% | +$34K | 0.35% | 52 |
|
|
2016
Q3 | $766K | Buy |
8,608
+151
| +2% | +$14.3K | 0.38% | 47 |
|
|
2016
Q2 | $810K | Buy |
8,457
+547
| +7% | +$54.5K | 0.42% | 44 |
|
|
2016
Q1 | $821K | Buy |
7,910
+156
| +2% | +$15.2K | 0.46% | 40 |
|
|
2015
Q4 | $758K | Buy |
7,754
+359
| +5% | +$35.2K | 0.42% | 45 |
|
|
2015
Q3 | $713K | Hold |
7,395
| – | – | 0.43% | 44 |
|
|
2015
Q2 | $776K | Sell |
7,395
-308
| -4% | -$31.5K | 0.47% | 43 |
|
|
2015
Q1 | $795K | Hold |
7,703
| – | – | 0.51% | 37 |
|
|
2014
Q4 | $742K | Sell |
7,703
-206
| -3% | -$18.2K | 0.49% | 41 |
|
|
2014
Q3 | $629K | Buy |
7,909
+426
| +6% | +$33.6K | 0.42% | 47 |
|
|
2014
Q2 | $564K | Hold |
7,483
| – | – | 0.41% | 46 |
|
|
2014
Q1 | $560K | Sell |
7,483
-36
| -0.5% | -$2.54K | 0.42% | 47 |
|
|
2013
Q4 | $538K | Buy |
7,519
+614
| +9% | +$39.5K | 0.4% | 51 |
|
|
2013
Q3 | $392K | Buy |
6,905
+1,281
| +23% | +$76.3K | 0.32% | 62 |
|
|
2013
Q2 | $322K | Buy |
+5,624
| New | +$326K | 0.28% | 65 |
|
Other funds holding CVS
Kistler-Tiffany Companies's CVS Position: Q2 2023 in Review
Kistler-Tiffany Companies reduced its CVS Health (CVS) stake by 15% in Q2 2023, selling an estimated $572K and leaving 46,181 shares worth $3.19M. The position accounts for 0.52% of the portfolio, ranked #35.
Kistler-Tiffany Companies first reported a position in CVS in Q2 2013 and has held it in 41 quarters since. The position peaked at $6.81M in Q4 2021. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.
- Kistler-Tiffany Companies held 46,181 shares of CVS Health worth $3.19M as of Q2 2023.
- Kistler-Tiffany Companies sold 8,035 CVS Health shares in Q2 2023, an estimated $572K.
- CVS Health made up 0.52% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #35 holding.
- Kistler-Tiffany Companies first reported a position in CVS Health in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's CVS Health position peaked at $6.81M in Q4 2021.
- 2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.